Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03136094 · ClinicalTrials.gov registry record · NA

Suicide in Urban Natives: Detection and Networks to Combat Events

A NA study of Suicide Prevention, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
698
Enrollment target
1
Study location

NCT03136094 is a NA study of Suicide Prevention that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 698 participants, below the 919-participant average among 21 other Suicide Prevention trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03136094, a NA study of Suicide Prevention, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
698 participants
Enrollment target
1
Study location

Study Summary

This study compares the effectiveness of a program to detect and manage suicide risk among American-Indian and Alaska Native (AI/AN) youth. Half of the participants will receive caring text messages to reduce suicidal thoughts, attempts, and hospitalizations and to increase engagement, social connectedness, and resilience in at-risk youth. The other half will receive usual care that does not include the caring text messages.

Conditions Studied

Interventions

  • BEHAVIORAL SBIRT+12
  • BEHAVIORAL SBIRT+Usual Care

Study Locations (1)

New Mexico

  • First Nations Community HealthSource - Albuquerque

Trial Details

FieldValue
Enrollment Target 698 participants
Start Date 2020-03-15
Est. Completion 2025-05-31
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT03136094

The ClinicalTrials.gov registry entry for NCT03136094 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 698 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 919-participant average among 21 other Suicide Prevention trials with a reported enrollment target (24% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 2 interventions - of which SBIRT+12 is the first listed.

NCT03136094 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.

Frequently Asked Questions

What is clinical trial NCT03136094 about?

NCT03136094 is a clinical study titled "Suicide in Urban Natives: Detection and Networks to Combat Events". This study compares the effectiveness of a program to detect and manage suicide risk among American-Indian and Alaska Native (AI/AN) youth. Half of the participants will receive caring text messages to reduce suicidal thoughts, attempts, and hospitalizations and to increase engagement, social connec...

What is the current status of trial NCT03136094?

This trial is currently recruiting. It is a NA study. The enrollment target is 698 participants. The study started on 2020-03-15. Estimated completion is 2025-05-31.

What conditions does trial NCT03136094 study?

This clinical trial studies the following conditions: Suicide Prevention.

What interventions are being tested in trial NCT03136094?

The interventions under investigation include: SBIRT+12 (BEHAVIORAL), SBIRT+Usual Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT03136094?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03136094 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.